Article
Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia.
Blood - 15 Nov 2002
Laverdière Caroline, Chiasson Sonia, Costea Irina, Moghrabi Albert, Krajinovic Maja
Abstract excerpt
Methotrexate (MTX) is a key compound of chemotherapeutic regimens used in the treatment of childhood acute lymphoblastic leukemia (ALL). Resistance to this drug may arise by, among other factors, altered cellular uptake that may hamper the efficacy of the treatment. Recently, a G(80)A polymorphis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
